Chiang C F, Tenenbaum S A, Verret C R, Leissinger C A, Garry R F
Department of Chemistry, Tulane University, New Orleans, Louisiana 70118, USA.
AIDS Res Hum Retroviruses. 1996 Feb 10;12(3):235-9. doi: 10.1089/aid.1996.12.235.
Cytotoxic CD8+ lymphocytes (CTLs) kill virally infected target cells by releasing cytotoxic granules. The primary objective of this study was to determine whether the activity of granzyme A, a serine protease in the killing granules of CTLs is altered in HIV-infected hemophiliacs. A sensitive colorimetric assay that measures cleavage of a synthetic substrate, N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT), was used to quantitate granzyme A activity. Granzyme A activities from hemophiliacs were normalized to to granzyme A activities of healthy donors run concurrently. Granzyme A activity in CD8+ T cells from HIV-seropositive hemophiliacs was significantly lower than granzyme A activity in cells from HIV-seronegative hemophiliacs (0.48 units +/- 0.086/CD8+ T cell and 1.573 +/- 0.434 units/CD8+ T cell, respectively; p < 0.005). These results indicate that cytotoxic cells in HIV-infected hemophiliacs have reduced granzyme A activity, which may result in a defect in CTL-mediated cell killing in these patients.
细胞毒性CD8 +淋巴细胞(CTL)通过释放细胞毒性颗粒来杀死病毒感染的靶细胞。本研究的主要目的是确定HIV感染的血友病患者中,CTL杀伤颗粒中的丝氨酸蛋白酶颗粒酶A的活性是否发生改变。使用一种灵敏的比色测定法来测量合成底物Nα-苄氧羰基-L-赖氨酸硫代苄酯(BLT)的裂解,以定量颗粒酶A的活性。将血友病患者的颗粒酶A活性标准化为同时检测的健康供体的颗粒酶A活性。HIV血清阳性血友病患者CD8 + T细胞中的颗粒酶A活性显著低于HIV血清阴性血友病患者细胞中的颗粒酶A活性(分别为0.48单位+/- 0.086 / CD8 + T细胞和1.573 +/- 0.434单位/ CD8 + T细胞;p <0.005)。这些结果表明,HIV感染的血友病患者中的细胞毒性细胞具有降低的颗粒酶A活性,这可能导致这些患者中CTL介导的细胞杀伤缺陷。